Cardiac involvement in metabolic diseases by PEREIRA, A. et al.
[Cardiac involvement in metabolic diseases] [Rev Port Cardiol. 1999] - PubMed result
Rev Port Cardiol. 1999 Jan;18(1):53-7.
[Cardiac involvement in metabolic diseases]
[Article in Portuguese]
Pereira A, Martins E, Carvalho C, Alvares S.
Unidade de Cardiologia Pediátrica, Hospital de Crianças Maria Pia.
Erratum in: 
l     Rev Port Cardiol 1999 Feb;18(2):131. 
Abstract
OBJECTIVE: To evaluate cardiac involvement in children with metabolic disease in the out patient 
clinic of the Pediatric Cardiology Unit of Maria Pia Children's Hospital and their follow-up.
MATERIAL AND METHODS: Twenty-nine medical records belonging to out patients with metabolic 
disease in consultation at our unit were reviewed. The following data from each record was analyzed: 
sex, metabolic disease diagnosis, age and motive for referral to a pediatric cardiology unit, cardiology 
diagnosis, therapy and evolution.
RESULTS: Seventeen patients were boys and 12 girls. The average age of referral was 7.2 years (SD 
4.8). The motives for referral were: screening for heart disease, 16; heart murmur, 7; congestive heart 
failure, 3; heart murmur and fatigue, 2; poor weight gain, 1. The following metabolic diagnoses were 
made: lysosomal diseases, 21; mitochondrial citopathies, 5; disorder of beta-oxidation of fatty acids, 2; 
carbohydrate deficient glycoprotein syndrome (CDG syndrome), 1. The cardiologic evaluation was 
normal in ten patients (4 with lysosomal disease, 4 with mitochondrial citopathy, one disorder of beta-
oxidation of fatty acids, the CDG syndrome). Mitral and aortic valve lesions predominated in lysosomal 
diseases (12/21); myocardial involvement alone was present in two patients, and both myocardial and 
valvular lesions were present in three. Dilated cardiomyopathy was the presented manifestation in two 
patients-one with mitochondrial citopathy and one with a disorder of beta-oxidation of fatty acids. Three 
patients died and 26 remain out-patients. One patient was submitted to valve surgery. The average 
duration of follow-up was 21 months (SD 24).
COMMENTS: Lysosomal diseases were the most representative in our patients, as described in the 
literature. Heart valve disease was the most frequent alteration. Indication for heart valve surgery is 
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dependent on systemic involvement of the primary disease. All children with a metabolic disease with 
eventual heart involvement should be evaluated periodically by a cardiology unit. On the other hand, it 
is mandatory to screen a cardiomyopathy of unknown cause for a metabolic disease. The authors draw 
attention to the importance of infectious endocarditis prophylaxis in this group of patients.
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